Thursday, 30 July 2015

Major Incident Management

Major Incident Management is a very common topic these days for FCEM OSCE as well as SAQ papers. I have written here the strip down version and the basics which will be sufficient for the exam.


Classification of major incident:

• A simple major incident is one in which the infrastructure of the community in which it occurs remains intact, e.g. a train or air crash

• A compound major incident destroys or damages the infrastructure of the surrounding community

• A compensated major incident is one in which there are sufficient local resources to deal with the consequences

• An uncompensated major incident is one where the medical and other responding emergency services are destroyed or totally inadequate.


CSCATTT


The mnemonic describes a system widely accepted in the UK, and now in many other countries, which is designed to ensure the successful medical management of a major incident with live casualties. It is a hierarchy of actions that help the otherwise potentially chaotic actions of multiple staff to come together into a system.


The sequence can be remembered using the acronym "Command Spells Calm And Time To Treat". The overriding aim of this approach is to achieve the common aims of all emergency services at a major incident.




CCOMMAND


SSAFETY


CCOMMUNICATION


AASSESSMENT


TTRIAGE


TTREATMENT


TTRANSPORT



Responsibilities of the first crew on scene:


An ambulance is likely to be at the scene at an early stage. If it is a major incident, the crew should not get involved in treating individuals but they need to assess the situation and report back to control. There will be an Ambulance Incident Officer (AIO) who is the senior crew member who is in charge until a more senior officer arrives. His tasks include:


  • Assessing the scene.

  • Declaring a major incident and giving a situation report (SITREP or METHANE).

  • Deciding where to locate the Control Point, Casualty Clearing Station (CCS), and Ambulance Parking Point, as well as planning ambulance entry and exit routes.

  • The AIO is in charge of communication with all health service personnel on the scene.

  • The AIO discusses with the chain of command the need for additional support, such as a Medical Incident Officer (MIO) on scene, the Medical Emergency Response Incident Team (MERIT) and additional equipment.

Reporting a major incident


This must go through the appropriate channels so that all necessary personnel and services are informed. Full and relevant information must be gathered. There are two mnemonics to help with this. They are METHANE and CHALETS and the contents are similar:




ajor incident declared
E xact location
T ype of incident, eg explosion and fire in a tall building, release of gas in the underground system
H azards - present and potential
A ccess - routes that are safe to use
N umber, type, severity of casualties
E mergency services now present and those required.


C asualties - number, type, severity
H azards present
A ccess routes that are safe to use
L ocation
E mergency services present and required
T ype of incident, as above
S afety.


By now there may be several ambulances on the scene but the control vehicle is recognised as the one that still displays its flashing lights.


The medical emergency response incident team (MERIT)


This team (formerly known as the Mobile Medical Team) usually consists of a doctor and a nurse or two of each. They should stay together unless ordered to do otherwise. Ideally, they should not come from the hospital that will be receiving casualties as they need all their staff but, in a remote area, this may not be practical. They should arrive equipped with kit bags. These contain limited airway, breathing and circulation equipment. 


When the MERIT arrives at the scene they should report to the MIO whose position will be apparent from a flashing green beacon. If none is present, they should report to the AIO at the ambulance with the flashing blue light. The team will probably be sent to the CCS but may be required to assist with the triage and treatment of entrapped casualties. It is not the role of the doctor or nurse to get involved in search and rescue, counselling victims or commanding ambulance personnel.


Organisation at the scene and away


Overall control of the scene is the responsibility of the police who will control the outer cordon.


There will be a police manned incident control point through which all staff should enter and leave; all movements will be logged


If hazards are present, the Fire service will have responsibility inside the inner cordon (the hot zone) until the danger is controlled


Personnel entering and leaving the inner cordon must also be recorded for safety purposes


The bronze ( operational) area lies within the inner cordon and is the area where the rescue operation is in place. There will be bronze commanders ( forward commanders) from each emergency service. It is a dangerous area and medical activity within it is limited to:


  • Primary triage.

  • Evacuation of casualties.

  • Treatment of trapped casualties.

Silver ( tactical) command consists of the area within the outer cordon. The commanders from each service will be within this area, although they may move in and out of the bronze zones


Gold ( strategic) command is removed from the scene – usually in the police HQ or local authority buildings – and is the location where the chief officers from each emergency service meet.


A doctor may also be required to certify death. Casualties are evacuated to the CCS that will be close to the scene yet at a safe distance and linked to the ambulance loading point. The CCS is for secondary triage, initial stabilisation and preparation for transportation to hospital.


Triage


Triage is a system for sorting casualties into priority for treatment by subsequent teams. It enables limited resources to be deployed efficiently. Treating a less critically ill patient could deny life-saving interventions to others who may die as a result. A form of rapid assessment is required and the triage sieve is usually employed. An experienced operator can perform this in about 20 seconds, so that it is possible to triage many people in a short time. Priorities are numbered 1 to 3 in descending order of need and are colour-coded as follows:


  • P1: immediate priority. It is those who will die without immediate lifesaving intervention. Colour code red.

  • P2: intermediate priority. They will also need significant interventions but can wait a few hours. Colour code yellow.

  • P3: delayed priority. They will need medical treatment, but this can safely be delayed. Colour code green.

  • Dead is a fourth classification and is important to prevent the expenditure of limited resources on those who are beyond help. Colour code black.

Walking wounded are automatically classified as P3. This is related to the motor score on the Glasgow Coma Scale and predicts favourable outcome. Time can be saved in the bronze zone by asking all who can proceed to the CCS unaided to do so, and automatically classifying them all as P3. This is a useful technique if the area is hazardous and it is necessary to clear it and move on the injured as soon as possible.


Casualties need to be labelled and the cruciate triage card is useful. It has 4 arms, coloured red, yellow, green and black and the appropriate arm can be displayed. It also facilitates change of category if required. If nothing else is available, write on the person"s forehead. Dead bodies should be left where they are, partly to avoid unproductive use of resources and partly because this may be a scene of crime.


It is quite common for up to 50% of patients to be triaged into too high a category, competing for limited resources. It is common for children to be placed in too high a category and old people in too low a category.


How to deal with the number of casualties


On site


By the time that the CCS is set up there may be adequate resources. As a general rule, advanced life support should not be performed in the bronze zone, as it is very labour intensive and the chance of success is limited. More lives will be saved by attention to others. At the CCS there may be enough staff to enable this to be performed without neglecting others who would benefit from immediate attention.


ED - the casualties


The first patients to arrive at the hospital A&E department are usually the least severely injured. This is because they are the most mobile and the more severely injured may require stabilisation before moving. Hence, the arrival of a large number of people who are not severely injured may be the trigger for the declaration of an emergency. Valuable resources such as ambulances should not be used to transport those who can use other means including cars, taxis or getting on a bus. Those who arrive in A&E have probably been triaged twice already but they will still require a further triage. A different system is required in hospital from in "the field". There is no uniform system but a common classification is resuscitation, major and minor.


Managing the casualty numbers in hospital


The hospital major incident plan can be activated either on the request of the Ambulance Service, or autonomously by the hospital. When a disaster is declared it is necessary to try to gauge the scale of the problem and to make a rough estimate of the number and nature of injuries. 


  • It is common practice for one hospital to be the reception centre for injuries whilst another sends out staff to the scene.

  • The receiving hospital needs all its staff on site.

  • A centre of operations is set up there with clinical and managerial input.

  • The clinical director should be a senior doctor with authority, who is not directly involved in the care of the injured, as he cannot do both jobs simultaneously. Hence, he or she will almost certainly not be the ED consultant or probably any surgeon.

  • The command and control centre will probably not be in ED, as it will be extremely busy there.

ED - the non-casualties


There will be the usual flow of patients from unrelated events in A&E. Someone has to deal with them or send them elsewhere. This may be to another hospital or asking GPs to cope.


  • If the system is stretched, patients from unrelated sources need to be put through the same triage procedures as those from the major incident.

  • It is inappropriate to send away someone with a serious medical need just because he or she is not a victim of the major incident.

  • It is still useful to note who was from the incident to help with inquires and also reflection on the adequacy of the operation afterwards.

Other hospital departments


All staff (and not just those skilled in the management of trauma) should report for duty when a hospital declares a major incident.


  • Other patients will still need care when perhaps their usual carers have been called away.

  • Someone may need to take the decision to discharge patients to free beds for new arrivals.

  • Routine admissions must be halted.

  • The extent to which this will need to be done depends on the anticipated number of admissions.

  • There should be a designated area where staff can report to in order to be assigned to their duties.

  • Standards of care must be maintained.

 


Major Incident Management

Saturday, 18 July 2015

Atrial Fibrillation

Atrial fibrillation (AF) is the most common cardiac arrhythmia. It is rarely a one-time event. Patients who develop AF once tend to be predisposed to developing it again & again. Current research indicates that this is primarily due to a change in the expression of ion channels that is caused by fibrillation (which may be mediated by changes in intracellular calcium caused by rapid pacing). This electrical remodelling creates an electrical “substrate” that is conducive to producing reentry. Some of the characteristics associated with AF are:



  • Symptoms: palpitations, dyspnea, fatigue, decreased exercise tolerance, chest pain



  • ECG: lack of P waves, “irregularly irregular” timing between QRS complexes & pulse pressure. The QRS complex & T waves are typically normal in duration & shape



  • Risk factors: hypertension, age, CHF, previous AF



  • Associated Pathology: atrial dilation, fibrosis, myocyte apoptosis



  • Complications: thromboembolism (due to vascular stasis in left atrium) & stroke



  • Common Origin & Mechanism: in patients with heart failure, an electrical focus around a left pulmonary vein combined with an abnormal atria; ablation of tissue around the pulmonary vein is one form of current therapy for patients with combined AF & heart failure (Khan et al., 2008).


There are two approaches to the treatment of AF:


  • Rate control, allowing AF to persist but controlling the ventricular rate by drugs affecting the AV node ERP (Effective Refractory Period), and

  • Rhythm control – with cardioversion to normal sinus rhythm & chronic treatment with antiarrhythmic drugs to prevent the reoccurrence of AF.

Arguments in favour of rate control include:


  1. Its easily achievable in most patients

  2. Avoidance of use of antiarrhythmic agents with less desirable side effects/toxicity

  3. Risk of stroke can be reduced by anticoagulant therapy

Arguments in favour of rhythm control include:


  1. Rhythm control reduces the odds of thromboembolism

  2. It was thought that patients who remain in AF have a worse outcome than those treated with drugs that maintain a sinus rhythm.

What does the evidence say?
In 2008, the results of two studies, one in North America, and one in Europe were published in the New England Journal of Medicine. In both studies, rhythm control provided no advantage over ventricular rate control with respect to survival (Fig 15A). On the basis of these results, rate control is currently considered an equally “safe” approach for the treatment of AF, and rhythm control (if it is used) can be abandoned early if it is not fully satisfactory (e.g. the patient cannot tolerate the side effects of the drugs used to suppress AF). Surgical procedures (e.g. Mini Maze procedure) involving catheter ablation of ectopic foci around the pulmonary veins may also be successful in patients with otherwise relatively normal hearts.


Figure 15. Panel A: Kaplan-Meier Estimates of Death from Cardiovascular Causes (Primary Outcome). Among 1376 patients with atrial fibrillation and congestive heart failure who were followed for a mean of 37 months, 182 patients (27%) in the rhythm-control group died from cardiovascular causes, as compared with 175 patients (25%) in the rate-control group (hazard ratio, 1.06; 95% confidence interval, 0.86 to 1.30). (From Roy et al, 2008). Panel B: Kaplan-Meier Estimates of the Percentage of Patients Remaining Free of Recurrence of Atrial Fibrillation in the two treatment groups (hazard ratio for recurrence among patients in the amiodarone group, 0.43 [95 percent confidence interval, 0.32 to 0.57]). Follow-up began 21 days after randomization (designated day 0). (From: Roy et al, 2000).


Currently amiodarone appears to be superior to other antiarrhythmics in preventing the reoccurrence of AFib (Figure 15B).


Initial conversion from AF to sinus rhythm can be achieved by either DC defibrillation or by an i.v. bolus of Amiodarone or Flecainide. Patients who are placed on rate control treatment are typically given maintenance therapy with either verapamil, diltiazem, a beta blocker or digoxin (digoxin use is more common if the patient has systolic HF).


NICE Recommendation (2014)


Perform manual pulse palpation to assess for the presence of an irregular pulse that may indicate underlying atrial fibrillation in people presenting with any of the following:


  • Breathlessness/dyspnoea

  • Palpitations

  • Syncope/dizziness

  • Chest discomfort

  • Stroke/transient ischaemic attack. [2006]


Perform an electrocardiogram (ECG) in all people, whether symptomatic or not, in whom atrial fibrillation is suspected because an irregular pulse has been detected. [2006]


Assessment of stroke and bleeding risks

Use the CHA2DS2-VASc stroke risk score to assess stroke risk in people with any of the following:


  • Symptomatic or asymptomatic paroxysmal, persistent or permanent atrial fibrillation

  • Atrial flutter

  • A continuing risk of arrhythmia recurrence after cardioversion back to sinus rhythm. [new 2014]

Use the HAS-BLED score to assess the risk of bleeding in people who are starting or have started anticoagulation.


Stroke prevention


  • Do not offer stroke prevention therapy to people aged under 65 years with atrial fibrillation and no risk factors other than their sex (that is, very low risk of stroke equating to a CHA2DS2-VASc score of 0 for men or 1 for women). [new 2014]

  • Consider anticoagulation for men with a CHA2DS2-VASc score of 1

  • Offer anticoagulation to people with a CHA2DS2-VASc score of 2 or above, taking bleeding risk into account.

  • Anticoagulation may be with apixaban, dabigatran etexilate, rivaroxaban or a vitamin K antagonist.



When to offer rate or rhythm control

Offer rate control as the first‑line strategy to people with atrial fibrillation, except in people:


  • Whose atrial fibrillation has a reversible cause

  • Who have heart failure thought to be primarily caused by atrial fibrillation

  • With new‑onset atrial fibrillation

  • With atrial flutter whose condition is considered suitable for an ablation strategy to restore sinus rhythm

  • For whom a rhythm control strategy would be more suitable based on clinical judgement.

Rate control


Offer either a standard beta‑blocker (that is, a beta‑blocker other than sotalol) or a rate‑limiting calcium‑channel blocker as initial monotherapy to people with atrial fibrillation who need drug treatment as part of a rate control strategy.


Consider digoxin monotherapy for people with non‑paroxysmal atrial fibrillation only if they are sedentary (do no or very little physical exercise).


If monotherapy does not control symptoms, and if continuing symptoms are thought to be due to poor ventricular rate control, consider combination therapy with any 2 of the following:


  • A beta‑blocker

  • Diltiazem

  • Digoxin.

Do not offer amiodarone for long‑term rate control.


Rhythm control


Consider pharmacological and/or electrical rhythm control for people with atrial fibrillation whose symptoms continue after heart rate has been controlled or for whom a rate‑control strategy has not been successful.


Cardioversion


For people having cardioversion for atrial fibrillation that has persisted for longer than 48 hours, offer electrical (rather than pharmacological) cardioversion.


Consider amiodarone therapy starting 4 weeks before and continuing for up to 12 months after electrical cardioversion to maintain sinus rhythm, and discuss the benefits and risks of amiodarone with the person.


For people with atrial fibrillation of greater than 48 hours" duration, in whom elective cardioversion is indicated:


Both transoesophageal echocardiography (TOE)‑guided cardioversion and conventional cardioversion should be considered equally effective.



Management for people presenting acutely with atrial fibrillation


Rate and rhythm control


  • Carry out emergency electrical cardioversion, without delaying to achieve anticoagulation, in people with life‑threatening haemodynamic instability caused by new‑onset atrial fibrillation.

  • In people with atrial fibrillation presenting acutely without life‑threatening haemodynamic instability, offer rate or rhythm control if the onset of the arrhythmia is less than 48 hours, and start rate control if it is more than 48 hours or is uncertain.

  • Consider either pharmacological or electrical cardioversion depending on clinical circumstances and resources in people with new‑onset atrial fibrillation who will be treated with a rhythm control strategy.

  • If pharmacological cardioversion has been agreed on clinical and resource grounds for new‑onset atrial fibrillation, offer:

  • Flecainide or amiodarone if there is no evidence of structural or ischaemic heart disease or

  • Amiodarone if there is evidence of structural heart disease.

  • In people with atrial fibrillation in whom the duration of the arrhythmia is greater than 48 hours or uncertain and considered for long‑term rhythm control, delay cardioversion until they have been maintained on therapeutic anticoagulation for a minimum of 3 weeks. During this period offer rate control as appropriate.

  • Do not offer magnesium or a calcium‑channel blocker for pharmacological cardioversion.

Anticoagulation


In people with new‑onset atrial fibrillation who are receiving no, or subtherapeutic, anticoagulation therapy:


  • In the absence of contraindications, offer heparin at initial presentation

  • Continue heparin until a full assessment has been made and appropriate antithrombotic therapy has been started

Useful Videos

Useful Videos








 


Atrial Fibrillation